These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 709256)

  • 1. How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis?
    Toft AD; Irvine WJ; Seth J; Cameron EH
    Br Med J; 1978 Oct; 2(6145):1115-7. PubMed ID: 709256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
    Tunbridge WM; Harsoulis P; Goolden AW
    Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma TSH and serum T-4 levels in long-term follow-up of patients treated with 131-I for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Seth J
    Br Med J; 1974 Jul; 3(5924):152-3. PubMed ID: 4136163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis.
    Toft AD; Irvine WJ; Seth J; Hunter WM; Cameron EH
    Lancet; 1975 Sep; 2(7935):576-8. PubMed ID: 51406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis.
    Sawers JS; Toft AD; Irvine WJ; Brown NS; Seth J
    J Clin Endocrinol Metab; 1980 Feb; 50(2):226-9. PubMed ID: 7354108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of 125I treatment of thyrotoxicosis.
    Bremner WF; Spencer CA; Ratcliffe WA; Greig WR; Ratcliffe JG
    Clin Endocrinol (Oxf); 1976 May; 5(3):225-34. PubMed ID: 954217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.
    Davies PH; Franklyn JA; Daykin J; Sheppard MC
    J Clin Endocrinol Metab; 1992 May; 74(5):1189-94. PubMed ID: 1569166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis.
    Hooper MJ; Ratcliffe JG; Ratcliffe WA; Spencer CA; McLarty DG; Alexander WD
    J Clin Endocrinol Metab; 1975 May; 40(5):807-11. PubMed ID: 47864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
    J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical value of a sensitive immunoradiometric assay for TSH.
    Allen KR; Scott RD; Hewitt JV; Watson D
    Ann Clin Biochem; 1985 Sep; 22 ( Pt 5)():506-8. PubMed ID: 4062219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-thyrotrophin and serum-thyroxine in patients becoming hypothyroid in the early months after iodine-131.
    Toft AD; Seth J; Hunter WM; Irvine WJ
    Lancet; 1974 Apr; 1(7860):704-5. PubMed ID: 4132423
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine].
    Hoogendoorn EH; Wiersinga WM; Prummel MF; den Heijer M; Corstens FH; Hermus AR
    Ned Tijdschr Geneeskd; 2004 May; 148(19):953-4. PubMed ID: 15160563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of serum thyroid hormone binding proteins after 131I treatment of hyperthyroidism.
    Harrop JS; Hopton MR; Lazarus JH
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):211-4. PubMed ID: 6269478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
    Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
    Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
    Schrub JC; Nouel JP; Brunelle P; Segond G; Courtois H; Poirier A
    Nouv Presse Med; 1976 May; 5(21):1346-8. PubMed ID: 778789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.